Treatment-Related Prostate Neuroendocrine Carcinoma
specificA prostate carcinoma with partial or complete neuroendocrine differentiation that results from the transformation of castration-resistant prostate adenocarcinoma following potent androgen-deprivation therapy. The prognosis is poor.
Top Centers for Treatment-Related Prostate Neuroendocrine Carcinoma
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →